| Date | Title | Description | Source |
| 12.03.2024 | T2 Biosystems Receives Extension to Comply with Nasdaq Listi... | - | globenewsw... |
| 20.02.2024 | T2 Biosystems Strikes Deal with CRG for Debt-to-Equity Conve... | T2 Biosystems, a pioneer in rapid sepsis detection, shakes hands with CRG to swap $15 million in deb... | parsers.vc... |
| 15.02.2024 | T2 Biosystems Announces Agreement with CRG for the Conversio... | LEXINGTON, Mass., Feb. 15, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in t... | einpresswi... |
| 15.02.2024 | T2 Biosystems Announces Agreement with CRG for the Conversio... | - | globenewsw... |
| 24.12.2021 | Microbix Biosystems Inc. Receives $4.7 Million Order for Vir... | Microbix Biosystems Inc. announces receipt of a follow-on order of CAD 4.7 million for its viral tra... | marketscre... |
| 07.10.2021 | T2 Biosystems : Development of a rapid, high sensitivity, di... | Development of a rapid, high sensitivity, direct from blood assay
for identification of biothreat or... | marketscre... |
| 19.11.2020 | Rebus Biosystems, Inc. Announces $20 Million Series B Financ... | | prnewswire... |
| 22.09.2016 | T2 Biosystems Announces $40 Million Equity Investment by Par... | LEXINGTON, Mass., Sept. 22, 2016 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a company dev... | aislingcap... |
| 29.06.2016 | The biotech IPO feast flags as investors lose their appeti... | There was a time after the 2008 crash that biotech IPOs were about as popular as snow in March. B... | endpts.com... |
| 19.08.2015 | Aisling Capital launching fourth, $400M life sciences fund | A document published on the Pennsylvania Public School Employees’ Retirement System indicated the fu... | medcitynew... |
| 28.03.2013 | T2 Biosystems Completes $40M Series E |
LEXINGTON, MA, T2 Biosystems today announced the completion of a $40 million financing led by new ... | vcnewsdail... |
| 28.03.2013 | T2 Biosystems Completes $40M Financing | T2 Biosystems, a Lexington, MA-based clinical diagnostics company, completed a $40m financing.
The r... | finsmes.co... |
| 28.03.2013 | T2 Biosystems’ Series E round reaches $40M | T2 Biosystems, which is developing a diagnostic device that uses magnetic resonance technology to de... | massdevice... |
| 28.03.2013 | Diagnostic to improve identification time for hospital acqui... | The test speeds up the detection time because it eliminates several steps from the current diagnosti... | medcitynew... |
| 22.03.2012 | Aligning Stakeholders in Emerging Med Tech Companies | So where do the wheels come off the bus? To answer this question, we sought the wisdom of John McDon... | medcitynew... |
| 10.08.2011 | T2 Biosystems Completes $23 Million Series D Financing | Lexington, MA, August 10, 2011 – T2 Biosystems® announced today that it has closed a $23 million ser... | aislingcap... |
| 10.08.2011 | T2 Biosystems Closes $23M Series D Financing | T2 Biosystems, a Lexington, MA-based developer of products designed to detect molecular and immunoas... | finsmes.co... |
| 10.08.2011 | T2 Biosystems Completes $23M Series D |
Round was led by new investor Aisling Capital, which was joined by existing investors Flagship Ven... | vcnewsdail... |
| 07.04.2011 | T2 Biosystems device cuts bloodstream infection detection fr... | T2 Biosystems Inc. says its new blood test for the cause of a deadly blood pathogen could help make ... | massdevice... |
| 15.03.2011 | Johnson & Johnson names new DePuy Spine president | Namal Nawana is the new president of DePuy Spine, succeeding Gary Fischetti, who was named chairman ... | massdevice... |
| 17.12.2010 | Sagentia chosen to drive development of T2 Biosystem's next ... | Sagentia chosen to drive development of T2 Biosystem's next generation medical diagnostic...
17-12-2... | cambridgen... |
| 14.12.2010 | T2 Biosystems hires UK firm to help develop portable diagnos... | The use of MR technology is faster, more reliable and may be less expensive for both molecular and i... | medcitynew... |
| 14.12.2010 | T2 signs Sagentia for nanotech diagnostics development | T2 Biosystems Inc. hired the Cambridge, U.K.-based consulting firm Sagentia to shepherd the developm... | massdevice... |
| 25.05.2010 | T2 Biosystems raises $15 million Series C round | T2 Biosystems Inc. raised about $15 million in a Series C funding round it plans to use to bring its... | massdevice... |
| 17.10.2008 | T2 Biosystems brings in $10.8M for diagnostics | T2 Biosystems, a company working to develop new diagnostic methods, received $10.8 million in second... | venturebea... |
| - | Aligning Stakeholders in Emerging Med Tech Companies | An emerging med tech company is like a family. There can be lots of drama. With the inevitable cycle... | medcitynew... |
| - | Aisling Capital launching fourth, $400M life sciences fund | Aisling Capital, a life sciences-focused private equity firm, is raising $400 million for its fourth... | medcitynew... |
| - | T2 Biosystems hires UK firm to help develop portable diagnos... | T2 Biosystems Inc. hired the Cambridge, U.K.-based consulting firm Sagentia to shepherd the developm... | medcitynew... |
| - | Diagnostic to improve identification time for hospital acqui... | A biotechnology company that’s developed a molecular diagnostic test platform to cut the time it tak... | medcitynew... |